Imunon, Inc. announced Dr. Corinne Le Goff, Pharm.D. has resigned as Chief Executive Officer to pursue another business opportunity. Dr. Le Goff?s resignation will be effective as of March 15, 2024. Michael H. Tardugno, the Company?s Executive Chairman, and Chief Executive Officer prior to Dr. Le Goff, will assume day-to-day leadership until a successor is named and will continue in his role directing Company strategy.